Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sen. Gregg To Propose Clinical Trial Database Act

This article was originally published in The Pink Sheet Daily

Executive Summary

Act would mandate registry of clinical trials performed for all U.S. marketed products only; competing bill calls for database of all drugs, biologics and devices.

You may also be interested in...



International Clinical Trials Portal Launched By Trade Group

International Federation of Pharmaceutical Manufacturers & Associations database includes 250,000 links to clinical trial data and provides searchable registry of ongoing trials, as well as links to completed trial results.

International Clinical Trials Portal Launched By Trade Group

International Federation of Pharmaceutical Manufacturers & Associations database includes 250,000 links to clinical trial data and provides searchable registry of ongoing trials, as well as links to completed trial results.

Hurricane Legislation Tables Drug Safety Issues

Congress will likely postpone consideration of drug safety issues to address emergency legislation relating to Hurricane Katrina, Senate Budget Committee Senior FDA Health Counsel Peggy Binzer said at the Food & Drug Law Institute conference on promotion and advertising Sept. 19

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS062901

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel